source
- Elicio Therapeutics’ KRAS pancreatic cancer vaccine fails in Phase 2, stock drops sharplyElicio Therapeutics reported that its KRAS‑targeted vaccine for pancreatic cancer did not improve patient outcomes in a mid‑stage (Phase 2) trial. The study results were released in a company state…
- Gan & Lee reports positive Phase 3 obesity trial results; J&J shares multiple myeloma dataGan & Lee Pharmaceuticals, a China‑based insulin specialist, announced topline results from its Phase 3 obesity trial, indicating a successful outcome. The company said the study met its primary e…